(Q51474049)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1 reference

acute promyelocytic leukemia

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Martin Hoglund

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

S Lehmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Ravn

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

L Carlsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

P Antunovic

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

S Deneberg

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

L Möllgård

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

A Rangert Derolf

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

D Stockelberg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

U Tidefelt

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

L Wennström

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

G Juliusson

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

19 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1128-1134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21502956%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.78

29 January 2020

exact match

0 references

cites work

Acute promyelocytic leukemia: recent advances in diagnosis and management

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Acute promyelocytic leukemia: from highly fatal to highly curable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Open issues on bleeding and thrombosis in acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

All-trans-retinoic acid in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Incidence rates of acute promyelocytic leukemia among Hispanics, blacks, Asians, and non-Hispanic whites in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

inferred from DOI database lookup

7 January 2021

based on heuristic

Clinical features and outcomes of 134 Brazilians with acute promyelocytic leukemia who received ATRA and anthracyclines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78

inferred from DOI database lookup

7 January 2021

based on heuristic

Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.78